Published in Obesity and Diabetes Week, June 19th, 2006
According to recent research from the United States, "AMPK is a key regulator of fat and carbohydrate metabolism. It has been postulated that defects in AMPK signaling could be responsible for some of the metabolic abnormalities of type 2 diabetes."
"In this study," proposed A. Sriwijitkamol and colleagues, University of Texas Health Science Center at San Antonio, "we examined whether insulin-resistant obese Zucker rats have abnormalities in the AMPK pathway."
They explained, "We compared AMPK and ACC phosphorylation and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.